Jan 19 (Reuters) - PolyPeptide Group AG PPGN.S:
POLYPEPTIDE SUCCESSFULLY CLOSES FINANCIAL YEAR 2025 WITH STRONG REVENUE GROWTH AND MARKED IMPROVEMENT IN PROFITABILITY
POLYPEPTIDE GROUP AG - FY REVENUE EUR 389 MILLION, GROWTH RATE +15.6%
POLYPEPTIDE GROUP AG - REAFFIRMS ITS MID‑TERM TARGETS TO DOUBLE REVENUE REPORTED FOR 2023 BY 2028
POLYPEPTIDE GROUP AG - CAPITAL EXPENDITURES EXPECTED OVER EUR 100 MILLION
POLYPEPTIDE GROUP AG - 2025 REACHING BETWEEN 11 - 12% EBITDA MARGIN TOWARDS UPPER END OF GUIDANCE AND UP FROM 7.5% IN 2024
Source text: ID:nEQspyHMa
Further company coverage: PPGN.S
(Gdansk Newsroom)
(((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600);))